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To prevent a recurrent stroke, carotid endarterectomy (CEA) is recommended within 14 days after transient 
ischemic attack or minor stroke caused by 50% to 99% ipsi-
lateral carotid stenosis1–3; the incidence of recurrent stroke is 
reported as high as 5% to 8% within the first 48 hours and 11% 
to 25% within 2 weeks.1 In the case of 70% to 99% stenosis, 
recurrent stroke can be efficiently prevented by CEA with the 
number-needed-to-treat of 5 to prevent 1 stroke when surgery 
is performed within 2 weeks.4 However, it remains controver-
sial whether CEA is safe within 48 hours from the most recent 
cerebrovascular symptom.5 National audit data from Sweden 
(SwedVasc) reported a 30-day stroke/death rate of 11.1% in 
those operated within 48 hours of symptom onset compared 
with 3.6% to 5.4% in those operated later.6 Subsequently, 
UK register also reported small but significantly increased 
risk related to performing CEA within 48 hours of symp-
tom onset (odds ratio, 1.64; 95% confidence interval [CI], 
1.04–2.59).7 However, German register did not find associa-
tion between the time from index symptom to CEA and the 
risk of any in-hospital stroke or death.8 The recent American 
Heart/Stroke Association guidelines recommend revascular-
ization between 48 hours and 7 days after nondisabling stroke 
(modified Rankin Scale [mRS] score of 0–2),2 whereas other 
guidelines do not take as clear opinion on the earliest timing 
of revascularization.
Many acute stroke patients are treated with intravenous 
thrombolysis (IVT), most often intravenous r-tPA (recombi-
nant tissue-type plasminogen activator) which increases the 
risk of bleeding both intracranially and locally. Furthermore, 
carotid stenosis patients often have impaired cerebral vasomo-
tor autoregulation because of exhausted vasomotor reserve, 
which lends them susceptible to hyperperfusion and intra-
cranial hemorrhage after CEA.9,10 Therefore, CEA is often 
postponed after IVT at the risk of stroke recurrence. Several 
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case series reporting outcome of CEA after IVT have been 
published. A meta-analysis of studies published until 201411 
and a Scandinavian multicentre case series of 202 IVT-treated 
patients found no evidence for an increased rate of complica-
tions within 30-day follow-up period after CEA.12 However, 
recent case series including patients operated within 24 to 72 
hours after CEA found a small and insignificant increase in 
30-day complication rate in IVT group when compared with 
non-IVT group.13,14
Reason behind the slightly increased complication rate of 
CEA performed within the first 48 hours after cerebrovascular 
symptoms is not fully elucidated; it is not known whether it is 
because of excess in bleeding complications as a result from 
hyperperfusion syndrome or embolic events from unstable 
carotid plaque. Furthermore, none of the earlier studies have 
taken into account the recurrent stroke rates during the waiting 
time for CEA, most probably because the data deriving from 
national registers often miss detailed clinical data on that time 
period. If the recurrence rate is higher than the perioperative 
risk, then the early operation may still be justified. The objec-
tive of our study was to investigate the safety and optimal tim-
ing of CEA after IVT by taking into consideration both the 
recurrent symptoms while waiting for CEA and the ischemic 
and bleeding complications peri/postoperatively.
Methods
The study was performed in Helsinki University Hospital (HUH), a 
tertiary hospital in southern part of Finland with a catchment popula-
tion of 1.6 million. During the year 2015, 250 CEAs and 330 IVTs 
were performed. Patients who underwent IVT because of a carotid 
territory stroke and a subsequent ipsilateral CEA between January 
2005 and December 2016 were identified from our hospital-based 
prospective registers, HUSVASC and Helsinki Stroke Thrombolysis 
Registry (Figure). The prospective databases for quality control have 
been maintained from 1995 for IVT and from 1990 for vascular sur-
gery procedures.
The HUSVASC register contains data on all the vascular proce-
dures performed in HUH. With respect to CEAs, the register includes 
demographic factors (the stenosis grade, sex, comorbidities, smok-
ing status, preoperative medication, and postoperative medication), 
type of the index symptom (ie, symptom that led to consultation and 
CEA: transient ischemic attack, amaurosis fugax, stroke or no symp-
tom), date of the index symptom, operation date, and stroke and death 
within the 30 days from CEA.
The Helsinki Stroke Thrombolysis Registry contains data on all 
patients who received IVT because of acute stroke in HUH. Data are 
collected on multiple variables including the time of stroke and IVT, 
stroke severity (National Institutes of Health Stroke Scale), imaging 
results, comorbidities, and 3-month outcome measured by mRS.
The patients were identified by linking the registers by personal 
identity code. The side of the symptomatic vessel (right or left carotid 
artery) was verified from medical records to ensure that the symptoms 
of acute stroke treated with IVT matched with the carotid artery oper-
ated. Data on recurrent cerebrovascular symptoms during the wait-
ing time for CEA, peri- and postoperative ischemic and hemorrhagic 
stroke within 30 days after CEA, bleeding complications, the signs of 
hyperperfusion syndrome, and myocardial infarction within 30 days 
from CEA were reviewed from medical records. Hyperperfusion 
syndrome was defined as follows: criterion A, a triad of high blood 
pressure, headache, and confusion and neurological symptoms 
resembling previous stroke without other cause and occurring within 
1 month after CEA; or criterion B, 2× higher mean blood flow veloc-
ity in the ipsilateral middle cerebral artery when compared with the 
contralateral middle cerebral artery in transcranial Doppler examina-
tion in combination with one of the symptoms listed above. In this 
study, all patients fulfilled the clinical criteria for the hyperperfusion 
syndrome (the A criterion). In addition, patients with elevated drug-
resistant postoperative blood pressure (above individually set target, 
usually systolic blood pressure >120–150 mm Hg for at least the first 
24 hours) requiring constant or repeated intravenous blood pressure 
medication and treatment in the intensive care unit were recorded. All 
patients who received IVT were either seen or contacted by telephone 
by a neurologist at 3 months after stroke.
Decision on IVT was made by a stroke neurologist according to 
the international guidelines.2,3 After IVT, the patients were monitored 
at the stroke unit for at least 24 hours, after which brain computed 
tomography (CT) or magnetic resonance imaging was performed. 
Antiplatelet therapy after IVT was designed individually taking into 
consideration previous medications, comorbidities (eg, atrial fibril-
lation or other cause for anticoagulation), and vessel pathology (eg, 
intraluminal thrombus). Most patients received aspirin 100 mg daily 
(or clopidogrel 75 mg daily if there existed a contraindication for 
aspirin) until CEA if there was no large infarct and hemorrhage in 
the control CT. If there was a high suspicion of intraluminal throm-
bus in the carotid artery, a combination of aspirin and low–molecular 
weight heparin was commonly used until surgery. A few patients did 
not receive any antiplatelet regimen because of emergency CEA.
Five patients received IVT in rural community hospitals via tele-
consultation of a neurologist in HUH and were transferred to HUH 
for follow-up and CEA. Relevant information on IVT was included 
in our hospital-based register and could be withdrawn from the medi-
cal records. Patients were included in this case series because these 
patients have been shown to have similar outcome with those treated 
at the emergency department of HUH.15
A consecutive series of 38 patients treated during 2008 to 2012 
were included earlier in the Scandinavian multicenter case series.12
As a control population, we used patients that underwent CEA 
because of stroke in 2008 to 2016 in HUH but were not treated with 
IVT before surgery (Figure). All patients were evaluated by a neu-
rologist and vascular surgeon before CEA. One month after CEA, 
they were met or contacted by a vascular surgeon or nurse. They were 
not routinely seen by a neurologist unless in need of rehabilitation 
evaluation or management.
Statistical analysis was performed with SPSS 22.0 statistical 
software (IBM SPSS Inc, Chicago, IL). Continuous variables are 
expressed as mean (95% CI) and dichotomous variables as percent-
age. Comparison between groups was performed with Student t test 
for continuous variables and χ2 for discrete variables. Logistic regres-
sion was used to model the effects of age, sex, vascular risk factors 
(smoking, hyperlipidemia), comorbidities, and medications on CEA-
related stroke as outcome. In the second model, only age, sex, and 
Figure. Flowchart of the study. CEA indicates carotid endarterectomy; IVT, 
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Table 1. Patient Characteristics and Outcomes by Sex
 All Males Females P Value*
Characteristics     
  No. of patients 128 94 (73.4%) 34 (26.5%)
  Age 68.9 (±9.2) 67.9 (±9.1) 71.7 (±8.9) 0.039†
  Current smoker 38 (29.7) 25 (26.6) 13 (38.2) 0.273
  Hypertension 99 (77.3) 73 (77.7) 26 (76.5) 1.000
  Diabetes mellitus (type I/II) 36 (28.1) 27 (28.7) 9 (26.5) 1.000
  Dyslipidemia 74 (57.8) 51 (54.3) 23 (67.6) 0.225
  Coronary heart disease 35 (27.3) 25 (26.6) 10 (29.4) 0.823
  Atrial fibrillation 9 (7.0) 7 (7.4) 2 (5.9) 1.000
  Previous stroke or TIA 37 (28.9) 28 (29.8) 9 (26.5) 0.827
  Medications     
   Antihypertensive 80 (62.5) 56 (59.6) 24 (70.6) 0.305
   Statin 58 (45.3) 44 (46.8) 14 (41.2) 0.688
   Antithrombotic 31 (24.2) 22 (23.4) 9 (26.5) 0.816
Stroke onset and IVT     
  Median NIHSS at stroke onset 6 (0–20) 6 (1–20) 6 (0–19) 0.834
  Time (min) from symptom-onset to IVT 120 (±54) 115 (±55) 131 (±52) 0.142
  Systolic BP before IVT 160 (±20) 158 (±20) 166 (±20) 0.046†
  Diastolic BP before IVT 82 (±14) 83 (±13) 78 (±15) 0.107
  Median NIHSS at 24 h 2 (0–22) 2 (0–22) 2 (0–15) 0.349
  ICH related to IVT 5 (3.9) 5 (5.3) 0 (0) 0.324
Time between symptom onset and CEA
  Recurrent preoperative stroke/TIA 7 (5.5) 6 (6.4) 1 (2.9) 0.674
  Time (days) to recurrence 4 (0–8) 4 (2–8) 0 0.117
CEA     
  Time (days) from IVT to CEA 9 (0–349) 9.0 (0–349) 8.5 (0–182)  
   CEA within 24 h 7 (5.5) 4 (4.3) 3 (8.8) 0.381
   CEA within 48 h 20 (15.6) 13 (13.8) 7 (20.6) 0.410
   CEA within 72 h 28 (21.9) 20 (21.3) 8 (23.5) 0.811
   CEA within 2 wk 87 (68.0) 62 (66.0) 25 (73.5) 0.522
  Peri/postoperative ischemic stroke within 30 days 5 (3.9) 2 (2.1) 3 (8.8) 0.116
  Time (days) from CEA to peri/postoperative stroke 2 (0–16) 1 3 (0–16) 0.642
  Hyperperfusion or drug-resistant hypertension 21 (16.4) 15 (16.0) 6 (17.6) 0.792
  Hyperperfusion syndrome 11 (8.6) 8 (8.5) 3 (8.8) 1.000
  ICH/hemorrhagic transformation 3 (2.3) 2 (2.1) 1 (2.9) 1.000
  Time (days) from CEA to ICH 4 (2–16) 9 (2–16) 4  
  CEA-related stroke 6 (4.7) 2 (2.1) 4 (11.8) 0.042†
  Exploration because of neck hematoma 11 (8.6) 11 (11.7) 0 (0.0) 0.036†
  Myocardial infarction 1 (0.8) 1 (1.1) 0 (0.0) 1.000
Outcome     
  All stroke 13 (10.2) 8 (8.5) 5 (14.7) 0.328
  Median mRS at 3 mo 1 (0–5) 1 (0–5) 2 (0–5) 0.231
   0–2 94 (73.4) 71 (75.5) 23 (67.6) 0.374
   3–5 34 (26.6) 23 (24.4) 11 (32.4) 0.374
  Mortality within 90 days 0 (0.0) 0 (0.0) 0 (0.0)  
Data given in number (%), mean (±SD), or median (range). BP indicates blood pressure; CEA, carotid endarterectomy; IVT, intravenous thrombolysis; mRS, 
modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and TIA, transient ischemic attack.
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variables having a significant effect on CEA-related stroke (ie, smok-
ing) were included.
The HUSVASC and the Helsinki Stroke Thrombolysis Registries 
have been approved by institutional authorities. According to Finnish 
legislation, no patient consent is required for registration in quality 
registries.
The authors declare that all supporting data are available within 
the article.
Results
Patient Characteristics and Stroke 
Onset in IVT-CEA Patients
During the years 2005 to 2016, 3454 IVT for acute stroke 
and altogether 2314 CEAs, of which 777 (33.6%) because 
of preceding hemispheric stroke, were performed in HUH 
(Figure). One hundred twenty-eight patients had both IVT 
and ipsilateral CEA, comprising 3.7% of all IVT-treated 
patients and 16.5% of the patients that underwent CEA 
because of stroke.
Of the IVT-treated patients, 73.4% were male (Table 1). 
Women were somewhat older (71.7 versus 67.9; P=0.039), but 
no other differences between genders were noted. On stroke 
onset, women had higher systolic blood pressure at admis-
sion (171±27 mm Hg in women and 159±23 mm Hg in men; 
P=0.029) and before IVT (Table 1).
Median National Institutes of Health Stroke Scale at 
stroke onset was 6 (range, 0–20; interquartile range, 6). Mean 
time from symptom onset to IVT was 120 minutes (95% CI, 
110–129). Median National Institutes of Health Stroke Scale 
at 24 hours was 2 (range, 0–22; interquartile range, 5). The 
rate of any ICH related to IVT (from hemorrhagic infarction 
to parenchymal hemorrhage) was 3.9%.
Recurrent Cerebrovascular Symptoms 
Before CEA in IVT-CEA Patients
Seven patients suffered a recurrent stroke or progression of 
symptoms (crescendo transient ischemic attack or stroke-in-
evolution) while waiting for CEA (incidence 5.5%, Table 1). 
These occurred at median 4 days from symptom onset (range, 
0–8 days). In most cases, recurrent symptom led to expedited 
surgery (median, 2 days; range, 0–5 days).
Table 2. Complications and Outcomes According to the Timing of CEA
 All CEA≤48 h CEA>48 h P Value*
No. of patients 128 20 108  
Stroke onset     
  Median NIHSS at stroke onset 6 (0–20) 5 (1–20) 6 (0–20) 0.519
  Median NIHSS at 24 h 2 (0–22) 2.5 (0–11) 2 (0–22) 0.878
  ICH related to IVT 5 (3.9%) 0 (0.0) 5 (4.6) 1.000
Time between symptom onset and CEA
  Recurrent preoperative stroke/TIA* 7 (5.5) 1 (5.0) 6 (5.6) 1.000
  Time (days) to recurrence 4 (0–8) 0 4 (2–8)  
CEA     
  Peri/postoperative ischemic stroke within 30 days 5 (3.9) 1 (5.0) 4 (3.7) 0.579
  Time (days) from CEA to peri/postoperative stroke 2 (0–16) 1 3 (0–16)  
  Hyperperfusion or drug-resistant hypertension 21 (16.4) 6 (30.0) 15 (13.9) 0.098
  Hyperperfusion syndrome 11 (8.6) 4 (20.0) 7 (6.5) 0.070
  ICH/hemorrhagic transformation 3 (2.3) 1 (5.0) 2 (1.9) 0.402
  Time (days) from CEA to ICH 4 (2–16) 2 10 (4–16)  
  CEA-related stroke 6 (4.7) 1 (5.0) 5 (4.6) 1.000
  Exploration because of neck hematoma 11 (8.6) 2 (10.0) 9 (8.3) 0.682
  AMI 1 (0.8) 0 (0.0) 1 (0.9) 1.000
Outcome     
  All stroke 13 (10.2) 2 (10.0) 11 (10.2) 1.000
  Median mRS at 3 mo 1 (0–5) 1 (0–3) 1 (0–5) 0.561
   0–2 94 (73.4) 16 (80.0) 78 (72.2) 0.588
   3–5 34 (26.6) 4 (20.0) 30 (27.8) 0.588
  Mortality within 90 days 0 (0.0) 0 (0.0) 0 (0.0)  
Data given in number (%), mean (±SD), or median (range). CEA indicates carotid endarterectomy; IVT, intravenous thrombolysis; mRS, 
modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and TIA, transient ischemic attack.
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CEA and Peri/Postoperative 
Complications in IVT-CEA Patients
CEA was performed median 9 days after IVT (range, 0–349 
days; interquartile range, 16; Table 1). There was a declin-
ing trend in the delay between IVT and CEA over the 10 
years study period: between 2005 and 2007, the median time 
was 25 days; during 2008 to 2010, 10 days; during 2011 to 
2013, 5 days; and between 2013 and 2016, 8 days. Seven 
patients (5.5%) had CEA within 24 hours from stroke onset, 
20 patients (15.6%) within 48 hours, and 87 patients (68.0%) 
within 14 days from stroke onset (Table 1.).
The incidence of peri/postoperative ischemic stroke was 
3.9% (n=5, Table 1). Strokes occurred in patients operated at 
median 12 days (range, 2–32 days) after IVT. There was no 
association between peri/postoperative ischemic stroke and 
the time between IVT and CEA (P=0.656). Furthermore, the 
incidence was not significantly increased in patients operated 
within 48 hours from IVT: 5.0% (n=1) in patients operated 
within 48 hours and 3.7% (n=4) in patients operated later 
(P=0.579; Table 2).
The incidence of hyperperfusion syndrome after IVT and 
CEA was 8.6%. In addition, 16% of patients had drug-resistant 
hypertension requiring frequent/continuous intravenous medi-
cation or treatment in an intensive care unit. Hyperperfusion 
was slightly but not significantly more common among 
patients operated within 48 hours after stroke onset than in 
patients operated with longer delay (20.0% versus 6.5%; 
P=0.070, respectively). In line, drug-resistant hypertension 
was twice as common in patients operated within 48 hours 
compared with later-operated patients (30.0% versus 13.9%; 
P=0.098). Altogether 3 patients suffered ICH or hemorrhagic 
transformation of ischemic infarct (incidence 2.3%), 1 had 
been operated within 48 hours and 2 with longer delay (5.0% 
versus 1.9%; P=0.402).
There were no obvious other complications in early-oper-
ated patients. Early- and later-operated patients did not differ 
in the incidence of neck hematomas requiring exploration or 
in the rate of myocardial infarctions (Table 2).
Overall, there were no differences in the incidence of 
CEA-related stroke (peri- and postoperative ischemic stroke 
or hemorrhagic stroke) in early-operated compared with later-
operated patients (5.0% versus 4.6%; P=1.000). With preop-
erative recurrences included, the incidence of all CEA-related 
strokes was 10.2% in patients operated within 48 hours and 
10.0% in patients with more delayed operation (P=1.000). 
None of the patients died within the 3-month follow-up period. 
Outcome measured by mRS was comparable (1 meaning no 
significant disability) in early- and later-operated patients 
(P=0.561).
Acute Thrombectomy/Endarterectomy Within 24 
Hours From Stroke Onset in IVT-CEA Patients
Six patients had emergency surgery within 24 hours from the 
stroke onset because of an acute occlusion of carotid artery 
(CCA or ICA, n=4) or progressing symptoms (stroke-in-evo-
lution, n=2) and no clinical response to IVT. Four patients had 
evidence of penumbra in CT perfusion imaging, whereas 2 
patients were operated based on brain CT and CT angiogra-
phy. In 1 patient, mechanical thrombectomy of M1 and bal-
loon angioplasty of ICA was performed after IVT and before 
CEA. In an additional seventh patient, CEA was performed 
within 24 hours from IVT and aspiration thrombectomy of 
Table 3. Logistic Regression Models With CEA-Related Stroke as Outcome
 β Significance OR 95% CI
Model A     
  Sex −1.693 0.167 0.184 0.017–2.030
  Age 0.149 0.052 1.160 0.999–1.348
  Smoking 3.083 0.044 21.820 1.083–439.576
  Diabetes mellitus type I or II −1.327 0.462 0.265 0.008–9.079
  Hypertension 1.684 0.270 5.387 0.271–107.093
  Hyperlipidemia 0.467 0.687 1.596 0.164–15.509
  Previous stroke or TIA 0.344 0.795 1.410 0.106–18.722
  Medications at stroke onset     
   Statin −2.302 0.244 0.100 0.002–4.797
   Antithrombotic 2.003 0.308 7.414 0.158–347.807
   Antihypertensive −2.201 0.129 0.111 0.006–1.893
  Time between IVT and CEA 0.015 0.299 1.015 0.987–1.043
Model B     
  Sex −1.156 0.239 0.315 0.046–2.152
  Age 0.114 0.086 1.121 0.984–1.276
  Smoking 2.756 0.022 15.740 1.492–166.003
  Time between IVT and CEA 0.005 0.701 1.005 0.980–1.031
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M1 occlusion. There were no perioperative ischemic or hem-
orrhagic strokes and none of these 7 patients died within 3 
months. One patient needed evacuation of a neck hematoma. 
The median 3-month mRS was 2 (range, 0–3).
Predictors for CEA-Related Stroke 
in IVT-CEA Patients
In multivariate analysis, the risk of CEA-related stroke (peri- 
or postoperative ischemic stroke or ICH related to hyperperfu-
sion syndrome) was not associated with the time between IVT 
and CEA (hazard ratio, 1.02; 95% CI, 0.99–1.04; Table 3). 
The only factor significantly associated with CEA-related 
stroke was smoking at time of stroke onset (odds ratio, 21.82; 
95% CI, 1.08–439.58). In bivariate analysis, women had more 
CEA-related strokes mainly because of higher incidence of 
peri/postoperative stroke (Table 1). However, after adjustment 
of other risk factors such as age and smoking, sex did not 
remain a significant predictive factor.
IVT-Treated Compared With Non-
IVT-Treated CEA Patients
Compared with controls (the patients who underwent CEA 
because of stroke but did not receive IVT), there was no dif-
ference in the rate of perioperative ischemic or hemorrhagic 
stroke (5.2% in non-IVT group and 4.7% in IVT group; 
P=1.000) or mortality within 30 days (0.6% in non-IVT group 
and 0.0% in IVT group; P=1.000).
Discussion
In this large and clinically comprehensive single-center 
study, we found no association between the time from IVT 
to CEA and the occurrence of peri/postoperative stroke or 
other CEA-related complications (neck hematoma or myo-
cardial infarction). Moreover, none of these complications 
was over-represented among the patients operated within 48 
hours from IVT. The perioperative stroke rate and mortality 
among 128 patients treated with thrombolysis before surgery 
was similar to that of the 777 stroke patients who underwent 
CEA with no prior IVT. Smoking status at the stroke onset 
was the only independent factor associated with the overall 
risk of stroke during the 30-day follow-up (odds ratio, 21.82; 
95% CI, 1.08–439.58). To our knowledge, the present study 
reports the largest single-center data on CEAs after IVT pub-
lished to date.
Drug-resistant hypertension and hyperperfusion syndrome 
tended to be more common in patients operated within 48 
hours; however, these did not lead to complications. This may 
be because of high level of suspicion and successful treatment 
of hypertension. One patient operated on the second day after 
stroke onset suffered contralateral stroke and small ipsilateral 
ICH within the ischemic brain region considered to result 
from hyperperfusion, but eventually recovered well (mRS 
score of 1 at 3 months). However, the 2 other hyperperfusion-
related ICHs occurred in patients that had been operated late, 
19 and 54 days after stroke onset. Both suffered severe hyper-
perfusion syndrome with ICH and status epilepticus and the 
other patient died 5 months later because of stroke and severe 
epileptic sequelae.
It is postulated that acute stroke particularly with under-
lying carotid stenosis is characterized by impaired cerebral 
autoregulation which in turn predisposes the patient to hyper-
perfusion syndrome after CEA.9,16 Our data seem to support 
this hypothesis, but there are also other factors that may 
explain the finding. In our hospital, patients are treated in a 
semi-intensive stroke unit at least 24 hours after IVT and if 
early operated on, they commonly return to the stroke unit 
after surgery and are continuously monitored. Therefore, early 
symptoms of hyperperfusion and resistant hypertension are 
more often registered and treated than in patients recovering 
from surgery in conventional ward, rehabilitation institute, or 
at home. Thus, the relatively high frequency of hyperperfu-
sion and drug-resistant hypertension in early-operated IVT 
patients may also reflect detection bias. This aspect is further 
supported by the fact that the 2 most severe cases of hyper-
perfusion syndrome in our cohort were seen in patients which 
were operated very late, 19 and 54 days after stroke onset and 
IVT. Thus, hyperperfusion may be more common and appear 
later that is generally considered.
Assuming the risk of hyperperfusion is truly increased 
after early CEA after IVT, the incidence of hyperperfusion-
related ICH could be higher also and explain the increased 
risk of complications associated with early surgery in some 
studies.6,7 According to our institutional guidelines, blood 
pressure of CEA patients is carefully controlled before and 
after CEA. The systolic blood pressure is kept <120 or 150 
depending on patients’ risk factors for hyperperfusion (severe 
stenosis, contralateral occlusion, high blood pressure before 
surgery or after CEA, increased intraoperative ICA flow mea-
sured with transit time flowmeter after clamp release). The 
optimal timing of the CEA is also decided in close collabo-
ration between vascular surgeons and neurologists. Without 
these precautions, the rate of ICH might be higher.
During the study period, our hospital practice for CEA 
changed and patients underwent CEA earlier after IVT: the 
median time decreased from 25 days in 2005 to 2007 to 8 
days in 2013 to 2016. In the beginning of our study period, 
most patients (68%) underwent CEA during the same index 
hospitalization within 2 weeks from stroke onset. From 2011 
onward, CEA was usually performed at first available urgent 
surgery slot if the patient was stable and no ICH was visible 
in the control CT at 24 hours after IVT. The most common 
causes to postpone surgery were a large infarct, IVT-related 
hemorrhagic transformation or ICH, or other complication 
(most commonly infection). When we analyzed our data in 
3-year time intervals (2005–2007, 2008–2010, 2011–2013 and 
2013–2016), we did not detect any increase in peri/postopera-
tive stroke rate. We noticed a slight increase in the incidence 
of drug-resistant hypertension and hyperperfusion (4.3% in 
2005–2007, 12.5% in 2008–2010, 24.3% in 2011–2013, and 
19.4% in 2013–2016) but whether this represents a true phe-
nomenon or detection bias discussed earlier is uncertain.
Limitations of the Study
Even though our hospital is a large tertiary hospital and we 
have gathered data on 11-year period, the number of patients 
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increase related to early CEA. However, there was only 1 isch-
emic and hemorrhagic stroke among patients operated within 
48 hours supporting a true low risk.
Our results are limited to patients with relatively minor 
stroke because the median National Institutes of Health Stroke 
Scale was 6 at stroke onset and 2 at 24 hours in our cohort. 
Furthermore, CEA was not performed in patients with large 
infarcts, hemorrhagic transformation or ICH, or other seri-
ous complication but was postponed until the patient was 
stabilized.
Our study design may underestimate the risk of recur-
rent stroke while waiting for CEA. Seven patients (5.5%) 
had recurrent stroke or progressing symptoms in the form of 
crescendo transient ischemic attacks or stroke-in-evolution 
between IVT and CEA, and in most of the cases, this led to 
expedited surgery. The number of patients with stroke while 
waiting for the operation (n=7) was similar to the number of 
patients with peri/postoperative stroke (n=6). Furthermore, 4 
patients got their index stroke while waiting for CEA, but these 
were not included as recurrent strokes in our analyses. Also a 
patient who would suffer a major stroke while waiting could 
be excluded from operation and so would not be included in 
our data. Thus, the overall incidence of recurrent strokes while 
waiting for CEA possibly exceeds that of peri/postoperative 
strokes. This underscores the importance of shortening the 
delay from IVT to CEA to decrease the total risk of stroke.
Conclusions
We found no association between the time from IVT to CEA 
and CEA-related complications. Furthermore, the compli-
cation risk of the IVT-CEA patients was not increased com-
pared with patients who underwent CEA alone. On the other 
hand, there were several recurrent strokes during the first 
week after stroke onset in the patients waiting for CEA. For 
patients who recover well with only minor deficits after IVT 
and with no IVT-related intracerebral hemorrhage, early 
CEA seems to be safe provided that blood pressure and the 
symptoms of hyperperfusion are carefully monitored and 
treated.
Sources of Funding




 1. Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, et al; Esvs 
Guidelines Committee; Esvs Guideline Reviewers. Editor’s choice - 
management of atherosclerotic carotid and vertebral artery disease: 2017 
clinical practice guidelines of the European Society for Vascular Surgery 
(ESVS). Eur J Vasc Endovasc Surg. 2018;55:3–81.
 2. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis 
NC, Becker K, et al; American Heart Association Stroke Council. 2018 
guidelines for the early management of patients with acute ischemic 
stroke: a guideline for healthcare professionals from the American Heart 
Association/American Stroke Association. Stroke. 2018;49:e46–e110. 
doi: 10.1161/STR.0000000000000158.
 3. European Stroke Organisation (ESO) Executive Committee; ESO 
Writing Committee. Guidelines for management of ischaemic stroke and 
transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457–507. 
doi: 10.1159/000131083.
 4. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid 
Endarterectomy Trialists Collaboration. Endarterectomy for symptom-
atic carotid stenosis in relation to clinical subgroups and timing of sur-
gery. Lancet. 2004;363:915–924. doi: 10.1016/S0140-6736(04)15785-1.
 5. Eckstein HH. Editorial on “Delays to Surgery and Procedural Risks 
Following Carotid Endarterectomy in the UK National Vascular 
Registry”. Eur J Vasc Endovasc Surg. 2016;52:425–426. doi: 
10.1016/j.ejvs.2016.07.085.
 6. Strömberg S, Gelin J, Osterberg T, Bergström GM, Karlström L, Osterberg 
K; Swedish Vascular Registry (Swedvasc) Steering Committee. Very 
urgent carotid endarterectomy confers increased procedural risk. Stroke. 
2012;43:1331–1335. doi: 10.1161/STROKEAHA.111.639344.
 7. Loftus IM, Paraskevas KI, Johal A, Waton S, Heikkila K, Naylor AR, 
et al. Editor’s choice - delays to surgery and procedural risks following 
carotid endarterectomy in the UK National Vascular Registry. Eur J Vasc 
Endovasc Surg. 2016;52:438–443.
 8. Tsantilas P, Kuehnl A, König T, Breitkreuz T, Kallmayer M, Knappich C, 
et al. Short time interval between neurologic event and carotid surgery is 
not associated with an increased procedural risk. Stroke. 2016;47:2783–
2790. doi: 10.1161/STROKEAHA.116.014058.
 9. van Mook WN, Rennenberg RJ, Schurink GW, van Oostenbrugge RJ, 
Mess WH, Hofman PA, et al. Cerebral hyperperfusion syndrome. Lancet 
Neurol. 2005;4:877–888. doi: 10.1016/S1474-4422(05)70251-9.
 10. Abreu P, Nogueira J, Rodrigues FB, Nascimento A, Carvalho M, 
Marreiros A, et al. Intracerebral hemorrhage as a manifestation of cere-
bral hyperperfusion syndrome after carotid revascularization: systematic 
review and meta-analysis. Acta Neurochir (Wien). 2017;159:2089–2097. 
doi: 10.1007/s00701-017-3328-4.
 11. Mandavia R, Qureshi MI, Dharmarajah B, Head K, Davies AH. 
Safety of carotid intervention following thrombolysis in acute isch-
aemic stroke. Eur J Vasc Endovasc Surg. 2014;48:505–512. doi: 
10.1016/j.ejvs.2014.08.012.
 12. Rathenborg LK, Venermo M, Troeng T, Jensen LP, Vikatmaa P, Wahlgren 
C, et al. Editor’s choice - safety of carotid endarterectomy after intrave-
nous thrombolysis for acute ischaemic stroke: a case-controlled multi-
centre registry study. Eur J Vasc Endovasc Surg. 2014;48:620–625.
 13. Bazan HA, Zea N, Jennings B, Smith TA, Vidal G, Sternbergh WC 
III. Urgent carotid intervention is safe after thrombolysis for minor to 
moderate acute ischemic stroke. J Vasc Surg. 2015;62:1529–1538. doi: 
10.1016/j.jvs.2015.07.082.
 14. Gunka I, Krajickova D, Lesko M, Renc O, Raupach J, Jiska S, et al. 
Safety of early carotid endarterectomy after intravenous thromboly-
sis in acute ischemic stroke. Ann Vasc Surg. 2017;44:353–360. doi: 
10.1016/j.avsg.2017.03.195.
 15. Sairanen T, Soinila S, Nikkanen M, Rantanen K, Mustanoja S, 
Färkkilä M, et al; Finnish Telestroke Task Force. Two years of Finnish 
Telestroke: thrombolysis at spokes equal to that at the hub. Neurology. 
2011;76:1145–1152. doi: 10.1212/WNL.0b013e318212a8d4.
 16. Xiong L, Liu X, Shang T, Smielewski P, Donnelly J, Guo ZN, et al. 
Impaired cerebral autoregulation: measurement and application 





 http://ahajournals.org by on A
ugust 14, 2018
